HUA MEDICINE (SHANGHAI) LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.59 HKD | -1.24% |
|
0.00% | -19.29% |
| 03-28 | Hua Medicine Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Hua Medicine Ltd. Appoints Yi Zhang as Executive Director with Effect from January 1, 2024 | CI |
Evolution of the average Target Price on Hua Medicine (Shanghai) Ltd.
Price target over the last 5 years
History of analyst recommendation changes
dfef2a3be11c8d84.bw1RP9VzDPKCEqFWKTyNJzlpgpJBfFIHhvfuWQJCl2E.AGEjVKEaasL3KpgCbVe_ZQwC0b90NwA3_M7ZalJz2EwNORtg4xdaveB_4A~ca7b361a539ac783c653c50dba7c57e3
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.473
CNY
Average target price
2.892
CNY
Spread / Average Target
+96.33%
High Price Target
2.892
CNY
Spread / Highest target
+96.33%
Low Price Target
2.892
CNY
Spread / Lowest Target
+96.33%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- 2552 Stock
- Consensus Hua Medicine (Shanghai) Ltd.
